Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians-Reference-Cited by-同舟云学术

Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians

Published:2017-12-28 Issue:2 Volume:16 Page:209-219
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Douxfils J.¹²^ORCID,Ageno W.³,Samama C.-M.⁴,Lessire S.⁵,ten Cate H.⁶,Verhamme P.⁷,Dogné J. -M.¹,Mullier F.⁸

Affiliation:

1. Department of Pharmacy; Namur Thrombosis and Hemostasis Centre (NTHC); Namur Research Institute for Life Sciences (NARILIS); University of Namur; Namur Belgium

2. Qualiblood s.a.; Namur Belgium

3. Department of Clinical and Experimental Medicine; University of Insubria; Varese Italy

4. Cochin University Hospital; Department of Anaesthesiology and Intensive Care; Université Paris Descartes; Paris France

5. Department of Anaesthesiology; Namur Thrombosis and Haemostasis Centre (NTHC); Namur Research Institute for Life Sciences (NARILIS); Université catholique de Louvain; CHU UCL Namur; Yvoir Belgium

6. Department of Internal Medicine; Maastricht University Medical Centre and Cardiovascular Research Institute (CARIM); Maastricht the Netherlands

7. Department of Cardiovascular Sciences; Vascular Medicine and Haemostasis; University of Leuven; Leuven Belgium

8. CHU UCL Namur; Laboratory Hematology, Namur Thrombosis and Haemostasis Centre (NTHC); Namur Research Institute for Life Sciences (NARILIS); Université catholique de Louvain; Yvoir Belgium

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.13912/fullpdf

Reference61 articles.

1. European Medicines Agency Xarelto - Summary of Product Characteristics 2017 http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000944/WC500057108.pdf

2. European Medicines Agency Pradaxa - Summary of Product Characteristics 2017 http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000829/WC500041059.pdf

3. European Medicines Agency Eliquis - Summary of Product Characteristics 2017 http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002148/WC500107728.pdf

4. European Medicines Agency Lixiana - Summary of Product Characteristics 2017 http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002629/WC500189045.pdf

5. Laboratory monitoring of non-vitamin K antagonist oral anticoagulant use in patients with atrial fibrillation: a review;Eikelboom;JAMA Cardiol,2017

Cited by 264 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparative in vitro study of the anticoagulant effect of branded versus generic rivaroxaban;Thrombosis Research;2024-03

2. Update on point-of-care-based coagulation treatment;Die Anaesthesiologie;2024-01-23

3. Retrospective study of clinical settings, indications and consequences of measurement of direct oral anticoagulant plasma levels in Northern Tasmania, Australia;Internal Medicine Journal;2024-01-11

4. Nomogram for predicting bleeding events in nonvalvular atrial fibrillation patients receiving rivaroxaban: A retrospective study;Health Science Reports;2024-01

5. Predictors of direct oral anticoagulant concentrations in the trauma population;Trauma Surgery & Acute Care Open;2024-01